Human cytoskeletal a-actinin cDNA was transfected into highly malignant simian virus 40-transformed BALB/c 3T3 (SVT2) cells that express 6-fold lower levels of a-actinin than nontransformed BALB/c 3T3 cells. SVT2 clones expressing various levels of a-actinin were isolated and their structure and tumorigenic properties were determined. Transfected SVT2 clones expressing a-actinin at levels found in nontumorigenic 3T3 cells displayed a flatter phenotype, a decreased ability to grow in suspension culture in soft agar, and a marked reduction in their ability to form tumors in syngeneic BALB/c mice and in athymic nude mice. Clones overexpressing a-actinin at the highest level (about 2-fold higher than 3T3 cells) were completely suppressed in their ability to form tumors in syngeneic BALB/c mice. The results suggest that a-actinin, an actin-crosslinking protein that is also localized in cell junctions, may have an effective suppressive ability on the transformed phenotype.
Malignant transformation of cells is characterized by alterations in cell growth, adhesion, motility, and cell shape (1) . Among the more conspicuous morphological alterations in transformed cells are a round phenotype and a decrease in the number of microfilament bundles (2, 3) . The disorganization of the actin filaments in transformed cells is often associated with a reduced expression of microfilament proteins such as tropomyosin (4) , gelsolin (5) , and vinculin (6) . These changes in microfilaments correlate with the ability of cells to grow in suspension in semisolid medium (7) .
Previous studies have demonstrated a reversion in the transformed phenotype of cancer cells in the presence of a variety of agents and a return to the original malignant behavior upon their removal (8) . This "reverse transformation" includes a reversible modulation in cell shape and the organization of the cytoskeleton (9) . However, the relationships between the changes in growth properties and the altered cell structure of transformed cells are still unknown (10) . Do the characteristic changes in cell morphology of transformed cells result from alterations in the rate of growth or are changes in cell adhesion and cytostructure responsible for disruption of the adhesion-dependent growth control? In this study we addressed this question directly by modulating the expression ofa single actin-associated protein a-actinin in a tumorigenic cell line and determined the consequences of altered a-actinin expression on the phenotype of the cells. a-Actinin is an abundant cytoplasmic actin-binding protein (11) that crosslinks actin filaments in vitro and is found in both muscle and nonmuscle cells (12, 13) . In striated muscle cells, a-actinin is localized in Z-disks; in smooth muscle cells, it is in dense plaques; and in nonmuscle cells, a-actinin is found along microfilaments (14) and in adherens junctions (AJs), at sites where actin filaments attach to the membrane (15) (16) (17) . The role of a-actinin in mediating actin attachment to the membrane is not completely understood. Recently, it has been shown that a-actinin can bind to the cytoplasmic domain of the transmembrane 31-integrin receptor (18) . The actin binding and the adhesion plaque targeting domains of a-actinin have been mapped using microinjection of purified a-actinin fragments and by cDNA transfection (19, 20) . Although a-actinin is a major and stable cellular protein, recent studies have demonstrated that its expression is regulated under various conditions. For example, after serum stimulation of quiescent 3T3 cells and in regenerating liver, the expression of a-actinin is elevated (21) . In contrast, during steroidogenesis (22, 23) and adipogenesis (24), a-actinin synthesis is reduced.
To determine the effect of changes in a-actinin expression on the tumorigenic ability of cells, we transfected human nonmuscle a-actinin into tumorigenic simian virus 40 (SV40)-transformed 3T3 (SVT2) cells that express a diminished level of a-actinin and isolated clones expressing different levels of the transgene. Cell structure and the tumorigenic ability of the various clones were determined. We show here that expression of high levels of human a-actinin in SVT2 cells suppressed dramatically the tumorigenicity of the cells in syngeneic animals and nude mice.
MATERIALS AND METHODS
Cell Culture and Transfection. BALB/c 3T3 clone A31 and SV40-transformed BALB/c 3T3 cells (SVT2) (25) were grown in Dulbecco's modified Eagle's medium plus 10% (vol/vol) fetal calf serum (GIBCO). The cells were transfected with a full-length human cDNA coding for the cytoskeletal nonmuscle a-actinin (26) that was cloned into the EcoRI site of the polylinker of the pJ41l expression vector (27) . The pJ4f vector consists of the Moloney murine leukemia virus long terminal repeat promoter-enhancer sequence, the SV40 small tumor antigen intron, and the SV40 large tumor antigen polyadenylylation signal in the pBR322 plasmid. The neomycin-resistance (neor) gene, which was cotransfected with the pJ41 construct containing the fulllength human a-actinin, was subcloned into the pSVL expression vector. Cells were transfected by the calcium phosphate precipitation method and colonies resistant to G418 (Geneticin; GIBCO) at 800 ,g/ml were isolated. Cells were also seeded at 2.5 x 102, 1 lowed by anti-mouse IgG coupled to alkaline phosphatase (Promega) or horseradish peroxidase, and detected by the enhanced chemiluminescence (ECL) method (Amersham). Two-dimensional (2D) gel electrophoresis was performed as described (28) . position of a-actinin on the 2D gels was identified by immunoblot analysis with the anti-a-actinin monoclonal antibody, followed by alkaline phosphatase-linked anti-mouse IgG. The levels of a-actinin were determined from the autoradiograms of fluorographed 2D gels by using a laser densitometer and computerized analysis ofthe images with the QUEST software system as described (29) . All protein spots of the 2D autoradiograms of each gel were matched by the computer and 50-100 protein spots were used for normalizing the different gels. The quantitative determination of the level of a-actinin was performed in such normalized gels.
Southern and Northern Blot Analyses. Total RNA was extracted by the guanidinium thiocyanate method (30) . Northern blots containing total RNA (20 pug per lane) were stained with methylene blue to determine the position of 18S and 28S rRNA markers and then hybridized (sequentially) with a-actinin and glyceraldehyde-3-phosphate dehydrogenase cDNA probes, which were labeled with P2P]dCTP by the random-priming technique (31), as described (32 (Fig. 1) . Total cell protein from cells labeled for 20 hr with [35Sjmethionine was analyzed by 2D gel electrophoresis, followed by transfer to nitrocellulose ( Fig. 1 A and  C) and identification of a-actinin by immunodetection on the same blots ( Fig. 1 B and D) . Quantitative computerized analysis of the autoradiograms of the 2D gels ( Fig. 1 A and C) revealed that the level ofa-actinin was -6-fold lower in SVT2 cells (Fig. 1C) compared to 3T3 cells (Fig. 1A) . Northern blots hybridized with a-actinin cDNA demonstrated that this decrease resulted from a similar reduction in a-actinin RNA content in SVT2 cells (Fig. 1 F vs. E) .
Transfection of SVT2 with Human a-Actinin. To study the effect of changes in a-actinin expression on SVT2 cell phenotype, the cells were cotransfected with a full-length human a-actinin cDNA (26) and with the neor gene. Colonies resistant to G418 were isolated and screened by quantitative immunoblot analysis with an anti-a-actinin antibody to detect clones expressing elevated levels of a-actinin (data not shown). Representative clones with different levels of a-actinin were labeled with [35S]methionine and the total protein pattern was obtained by 2D gel electrophoresis (Fig. 2) . Exogenous and endogenous a-actinin comigrated in 2D gel analyses. This was expected, as a-actinin is a very highly conserved molecule with =99%o homology between chicken and human nonmuscle a-actinin (26) . Computerized analysis of the autoradiograms shown in Fig. 2 demonstrated that clones expressing 4-fold (Fig. 2B), 7-fold (Fig. 2C) , and 10-fold (Fig. 2D) higher levels of a-actinin were obtained when compared to a neor SVT2 control (Fig. 2A) . The presence of the transgene in the transfected clones was confirmed by Southern blot analysis (Fig. 3A) . Sa29 and Sal were shown to contain the 3.1-kilobase EcoRI fragment corresponding to the full-length a-actinin cDNA (Fig. 3A,   lanes 1 and 2) , whereas in the neor control and SVT2, this fragment was absent (Fig. 3A, lanes 3 and 4) .
To determine the level of exogenous vs. endogenous a-actinin in the transfected clones, a Northern blot containing RNA from the various clones was hybridized with the human a-actinin cDNA (Fig. 3B) . The endogenous a-actinin RNA appeared as a 3.2-kilobase species, and the exogenous RNA was the faster migrating species (Fig. 3B) (Fig. 2) , and the copy number of the integrated DNA did not always correlate with the level of a-actinin in the different clones (Fig. 3A) . The endogenous a-actinin RNA content remained largely unaltered in the transfected clones. Imc at of a-Actlb in Transfected SVT2 CeRs. SVT2 cells have very few stress fibers with actin staining mainly at the cell periphery (Fig. 4B) , whereas 3T3 cells display an extensive stress fiber system (Fig. 4A) . Staining with a broad-range anti-a-actinin antibody demonstrated that a-actinin followed the distributionofactin in both 3T3 (Fig. 4D ) and SVT2 cells (Fig. 4E) . In 3T3 cells, a-actinin showed a periodical distribution along stress fibers and strong staining of adhesion plaques (Fig. 4D) . SVT2 cells had a punctate cytoplasmic staining and a-actinin was also found in peripheral ruffles (Fig. 4E) syngeneic BALB/c mice and tumor formation was followed (Table 1) . SVT2 cells and neor controls formed rapidly developing tumors that were palpable after 1 week and increased to 4-6 cm in diameter in 3 weeks. The ability of SVT2 cells expressing increasing levels of the human a-actinin to form tumors was markedly suppressed and correlated with the level of a-actinin in the transfected cells (Table 1) . Similar results were obtained when these cells were injected into nude mice. Although tumor formation was not completely suppressed in nude mice, the rate of tumor formation was delayed and their size was significantly reduced in a-actinin overexpressors (4.3-fold in Sa29; Table 1 ). In addition, cells expressing increased levels of a-actinin had an =7-fold lower ability to grow in soft agar (Table 1) .
DISCUSSION
In this study we have demonstrated that, in a highly malignant cell line, tumorigenicity can be markedly suppressed by Table 1 modulating the expression of a single actin-binding protein, a-actinin. We have studied a-actinin, since it is a major component involved in microfilament stabilization and in linking microfilaments to AJs (34) . In addition, a-actinin expression is modulated during growth activation and differentiation (21) (22) (23) (24) and is significantly decreased in SVT2 cells. The relationship between a-actinin expression and the tumorigenic phenotype was addressed directly by elevating a-actinin levels in tumor cells that express diminished amounts of this protein. The results have shown that suppression of the tumorigenic ability of the cells in experimental animals correlated with the level of a-actinin expressed in the different clones. In SVT2 clones expressing a-actinin at levels close to that of nontransformed 3T3 cells and above, tumorigenicity was drastically reduced, whereas clones expressing low levels of the transgene were as tumorigenic as the neor controls. Several lines of evidence suggest that the effect observed is specific for the increased expression ofa-actinin: After passage of clones expressing elevated a-actinin levels for several months in culture, revertants were obtained that have lost exogenous a-actinin expression, due to the loss of integrated a-actinin plasmid, as determined by Southern blot hybridization (data not shown). These clones were as tumorigenic as the parental SVT2 clone. The Southern blot analyses have also shown that a large copy number of the integrated transgene do not correlate directly with the amount ofthe transfected a-actinin, only the elevated level of the protein correlated with the suppression ofthe tumorigenic phenotype (Fig. 3) . The 2D gel analyses of clones expressing increased levels of a-actinin did not detect changes in the synthesis of other microfilament proteins such as the nonmuscle tropomyosin isoforms, actin, or vinculin or in the level of the cytoskeletal proteins tubulin and vimentin. Since nonmuscle a-actinin is a very highly conserved protein [99% homology between chicken and human sequences (26) ], the difference between human and mouse a-actinin sequences is most probably not responsible for the observations reported here. The ability to suppress the tumorigenicity of the transfected cells is, therefore, attributable to the specific increase in a-actinin expression in these cells.
The mechanism responsible for the suppression of the tumorigenic phenotype in a-actinin-transfected cells is not clear. Since a-actinin is a major structural component of microfilaments and AJs, it may exert its effect on cellular properties by influencing microfilament organization and/or cell adhesion and motility. The immunofluorescence results of this study showing a reversal to a more extended phenotype in cells expressing elevated levels of a-actinin support this proposal. a-Actinin is known to crosslink microfilaments by binding to itself to form a homodimer and is involved in binding actin-filaments to the membrane by binding to other components of the AJ including vinculin, zyxin, and Piintegrin (17, 18, 35, 36) . AJs are considered dynamic structures whose components are present in assembled or unassembled (soluble) pools between which a dynamic equilibrium is maintained (37) . Modulations in this equilibrium in one direction or the other will result in junction disassembly and decreased adhesion or, conversely, in the formation of extended junctions and increased adhesion. Furthermore, the interaction between cytoplasmic AJ components (e.g., talin, vinculin, a-actinin, and actin) is a highly cooperative process with a very efficient ability to recruit components from the soluble pool and to assemble them into AJs (38) . According to this model, an increase in a-4ctinin levels will lead to increased a-actinin in AJs of the transfected cells, which will then lead to the formation of more stable microfilament-membrane interactions, increased adhesion, and decreased motility.
Several recent transfection studies with other microfilament-associated proteins are in agreement with this notion: For example, overexpression by only 20%o of another AJ protein, vinculin, in nontransformed 3T3 cells was sufficient to significantly suppress cell motility (39) . The migration of 3T3 cells toward a chemoattractant was increased in cells expressing 25% more gelsolin, a microfilament-severing protein (40) . Transfection of actin-binding protein, a crosslinker of actin filaments, into human melanoma cell lines deficient in this protein restored translocation and motility and reduced membrane blebbing (41) . It should be interesting to determine whether changes in the expression of these other actin-associated proteins will also have an effect on the tumorigenic ability of tumor cells.
Recombinant DNA expression experiments with cell adhesion receptors, which are known to associate with the microfilament system in AJs (17) , have demonstrated an effect on both cell motility and the tumorigenic phenotype of cells. Transfection of the fibronectin receptor as51-integrin (42) or of E-cadherin into various transformed cells resulted in increased adhesion, decreased motility, and suppression of the tumorigenic ability of the cells (43) (44) (45) (46) . It appears that modulation of the assembly of the structural AJ complex that links the outside to the inside of the cell and consists of the cadherins, integrins, the cytoplasmic plaque components, and the microfilaments, not only may affect motility and adhesion, but also can generate long-range signals that will affect cell growth and the tumorigenic ability of cells.
